DEHP:NYE-Dimensional ETF Trust - Dimensional Emerging Markets High Profitability ETF (USD)

ETF | Others |

Last Closing

USD 25.06

Change

0.00 (0.00)%

Market Cap

USD 0.21B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The Portfolio is designed to purchase securities of large companies associated with emerging markets that the Advisor determines to have high profitability relative to other large companies in the same country or region at the time of purchase. The Advisor intends to purchase securities of large companies that are associated with emerging markets, which may include frontier markets (emerging market countries in an earlier stage of development).

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-17 )

ETFs Containing DEHP

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.35% 39% F 42% F
Dividend Return 1.97% 40% F 36% F
Total Return 5.32% 32% F 36% F
Trailing 12 Months  
Capital Gain 7.05% 39% F 40% F
Dividend Return 2.48% 42% F 34% F
Total Return 9.53% 35% F 35% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 3.57% 61% D- 47% F
Dividend Return 4.84% 64% D 44% F
Total Return 1.28% 55% F 31% F
Risk Return Profile  
Volatility (Standard Deviation) 6.49% 73% C 88% B+
Risk Adjusted Return 74.65% 81% B- 86% B+
Market Capitalization 0.21B 72% C 36% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike